Tower Research Capital (TRC)’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2K | Buy |
12,246
+2,337
| +24% | +$5.77K | ﹤0.01% | 3393 |
|
|
2025
Q1 | $19.7K | Buy |
9,909
+8,512
| +609% | +$16.9K | ﹤0.01% | 2985 |
|
|
2024
Q4 | $4.08K | Sell |
1,397
-6,652
| -83% | -$19.4K | ﹤0.01% | 4520 |
|
|
2024
Q3 | $31.2K | Buy |
8,049
+2,892
| +56% | +$11.2K | ﹤0.01% | 2978 |
|
|
2024
Q2 | $26.5K | Sell |
5,157
-1,906
| -27% | -$9.8K | ﹤0.01% | 3575 |
|
|
2024
Q1 | $49.4K | Sell |
7,063
-13,948
| -66% | -$97.6K | ﹤0.01% | 2285 |
|
|
2023
Q4 | $186K | Buy |
21,011
+17,483
| +496% | +$155K | ﹤0.01% | 2168 |
|
|
2023
Q3 | $33.7K | Buy |
3,528
+385
| +12% | +$3.67K | ﹤0.01% | 2920 |
|
|
2023
Q2 | $46K | Sell |
3,143
-82
| -3% | -$1.2K | ﹤0.01% | 2629 |
|
|
2023
Q1 | $40K | Buy |
3,225
+2,852
| +765% | +$35.4K | ﹤0.01% | 2716 |
|
|
2022
Q4 | $7K | Buy |
+373
| New | +$7K | ﹤0.01% | 4604 |
|